AI assistant
Sending…
Tvardi Therapeutics, Inc. — Director's Dealing 2021
Nov 3, 2021
9999_dirs_2021-11-03_603a698a-43d0-4a65-a0b4-d47be5935e36.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Cara Therapeutics, Inc. (CARA)
CIK: 0001346830
Period of Report: 2021-11-01
Reporting Person: Goncalves Joana (Chief Medical Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-11-01 | Common Stock | S | 1000 | $17.15 | Disposed | 45900 | Direct |
Footnotes
F1: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 13, 2021.
More from Tvardi Therapeutics, Inc.
Interim / Quarterly Report
2026
May 8
Earnings Release
2026
May 8
Regulatory Filings
2026
Apr 1
Annual Report
2026
Apr 1
Director's Dealing
2026
Feb 2
Director's Dealing
2026
Feb 2
Director's Dealing
2026
Feb 2
Director's Dealing
2026
Feb 2
Investor Presentation
2026
Jan 16
Board/Management Information
2025
Dec 18